Covered recipient · General Payments record
ABBY ALYSSE GASKELL
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,593.37
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $508.84 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Galderma Laboratories, L.P. | $244.79 | 7 |
| ABBVIE INC. | $219.92 | 9 |
| MERZ NORTH AMERICA, INC. | $44.13 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.47 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155386 | CMS |
| ABBVIE INC. | $17.51 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155388 | CMS |
| ABBVIE INC. | $14.80 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155390 | CMS |
| ABBVIE INC. | $25.81 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155392 | CMS |
| ABBVIE INC. | $27.48 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155394 | CMS |
| ABBVIE INC. | $25.59 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155396 | CMS |
| ABBVIE INC. | $31.56 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155398 | CMS |
| ABBVIE INC. | $27.55 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155400 | CMS |
| ABBVIE INC. | $33.15 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155402 | CMS |
| Galderma Laboratories, L.P. | $7.47 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359078 | CMS |
| Galderma Laboratories, L.P. | $20.61 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359080 | CMS |
| Galderma Laboratories, L.P. | $134.24 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359082 | CMS |
| Galderma Laboratories, L.P. | $6.59 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359084 | CMS |
| Galderma Laboratories, L.P. | $12.51 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359086 | CMS |
| Galderma Laboratories, L.P. | $15.07 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359088 | CMS |
| Galderma Laboratories, L.P. | $48.30 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359090 | CMS |
| MERZ NORTH AMERICA, INC. | $22.87 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146376386 | CMS |
| MERZ NORTH AMERICA, INC. | $21.26 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146376384 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.